In the News

Reimagine Care Welcomes Dan Nardi, Healthcare Industry Leader, as New CEO

Reimagine Care has announced that Dan Nardi will serve as its new Chief Executive Officer, effective July 10, 2023. Nardi replaces co-founder Dr. Aaron Gerber as CEO. Previously, Nardi served as Carrum Health’s Chief Operating Officer and Livongo’s Vice President of Operations. He brings to the...

Kathleen Bresette named chief revenue officer at RxLightning

RxLightning has hired Kathleen Bresette as its first chief revenue officer. Bresette’s experience in the health care industry is expansive. Most recently, she served as vice president of business development and client strategy at DrFirst Inc. She was also previously the chief revenue officer for...

Merck Digital Sciences Studio’s SciMar ONE is already demonstrating early value

Last year, McKesson Ventures joined a group of funders including Merck, Microsoft, the Global Health Innovation Fund, Northpond Ventures, and the New Jersey Institute of Technology to bring to life a “founder-friendly” startup accelerator for companies in the biopharma industry. That accelerator is the Merck...

Clinical ink Appoints Andrew Kraus as Chief Technology Officer

Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an accomplished global healthcare executive with a...

McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors

McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are recognized as leaders by portfolio company CEOs,...

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trials in Sleep and Neurologic Disorders Using EEG Biomarkers

Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon platform unlocks longitudinal, at-home EEG technology, applies machine-learning algorithms to maximize...

Xealth Is Honored In 25th Anniversary Digital Health Awards®

McKesson Ventures portfolio company Xealth was selected as a winner in the 25th anniversary Digital Health Awards® program. This competition recognizes the best digital health resources. “Shaping Your Digital Health Future” received a Gold Award for Connected Digital Health: Consumer Directed Digital Health Programs. “Digital solutions are...

Real-Time Clinical Trial Monitoring at Clinical ink

Clinical Ink Senior Director Enterprise Architecture Alex Doan recently wrote a case study about how the company chose to use the Rockset analytics platform to improve query speed and other performance metrics. He began by explaining Clinical Ink, which he described as a suite of software...

McKesson Ventures’ Carrie Williams Speaks at 2023 DHIS Conference

[caption id="attachment_54085" align="alignright" width="400"] McKesson Ventures Vice President & Partner Carrie Williams spoke at the recent DHIS East Coast summit in Boston.[/caption] McKesson Ventures Vice President & Partner Carrie Williams spoke at the Digital Healthcare Innovation Summit, East Coast, which took place June 6 and 7,...